REQUEST A DEMO
Total
USD $0.00
Search more companies

Unidad De Diagnostico Y Tratamiento Urologico S.A.S. Uromed S.A.S (Colombia)

Main Activities: General Medical and Surgical Hospitals
Full name: Unidad De Diagnostico Y Tratamiento Urologico S.A.S. Uromed S.A.S Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Unidad De Diagnostico Y Tratamiento Urologico S.A.S. Uromed S.A.S is a company based in Colombia, with its head office in Santa Marta. It operates in the General Medical and Surgical Hospitals industry. It was incorporated on December 16, 2004. Unidad De Diagnostico Y Tratamiento Urologico S.A.S. Uromed S.A.S currently employs 9 (2018) people. From the latest financial highlights, Unidad De Diagnostico Y Tratamiento Urologico S.A.S. Uromed S.A.S reported a net sales revenue increase of 25.25% in 2023. Its’ total assets recorded a growth of 2.52%. The net profit margin of Unidad De Diagnostico Y Tratamiento Urologico S.A.S. Uromed S.A.S decreased by 2.02% in 2023.

Headquarters
Cr 15 22 54
Santa Marta; Magdalena;

Contact Details: Purchase the Unidad De Diagnostico Y Tratamiento Urologico S.A.S. Uromed S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Unidad De Diagnostico Y Tratamiento Urologico S.A.S. Uromed S.A.S report to view the information.
Outstanding Shares:
Purchase the Unidad De Diagnostico Y Tratamiento Urologico S.A.S. Uromed S.A.S report to view the information.
Incorporation Date:
December 16, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Unidad De Diagnostico Y Tratamiento Urologico S.A.S. Uromed S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
25.25%
Total operating revenue
25.25%
Operating profit (EBIT)
-5.61%
EBITDA
4.39%
Net Profit (Loss) for the Period
8.84%
Total assets
2.52%
Total equity
20.02%
Operating Profit Margin (ROS)
-8.05%
Net Profit Margin
-2.02%
Return on Equity (ROE)
-3.17%
Quick Ratio
0.24%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?